Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
The serotonin transporter gene promoter polymorphism (5-HTTLPR) has been repeatedly associated with antidepressant response in mood disorder patients, but findings are not consistent across studies. A meta-analysis was performed on 15 studies including data of 1435 subjects. We tested three phenotypes: remission rate, response rate and response rate within 4 weeks using the cochrane review manager. We observed a significant association of the s/s variant of 5-HTTLPR with remission rate (P<0.0001) and both s/s and s/l variants with response rate (P=0.0002). Response rate within 4 weeks was associated in both models (P=0.003-P<0.00001). This effect is quite robust to ethnic differences although a significant heterogeneity is present in Asian samples.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“L-alleles result in greater mRNA transcription and more active 5-HTT function (Parsey et al., 2006) and have been associated with a better treatment response to selective serotonin reuptake inhibitor (SSRI) antidepressants although discrepant findings exist (Serretti et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Serretti et al., 2007
Citations
Cites
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Hu, X.-Z., Lipsky, R. H., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B. D., Xu, K., Arnold, P. D., Richter, M. A., Kennedy, J. L., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,123
(1994) · PharmacoResources · doi:10.1007/bf03289581 · Cited by 974
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Meta-analysis of genetic association studies
Munafò, M. R., & Flint, J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.014 · Cited by 642
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000698 · Cited by 633
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Perez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Cited by
Items 401–500 of 535
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 3
Intervention options: depression and cardiovascular disease during COVID-19
Flouda, E., Stefanatou, A., & Apergi, T. (2023) · Global Cardiology · doi:10.4081/cardio.2023.5 · Cited by 2
Pharmacogenomics of Psychotropic Drugs
Serretti, A. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.125 · Cited by 2
Self-citationApplication of Pharmacogenomics to Clinical Problems in Depression
Oestergaard, S., & M⊘ldrup, C. (2009) · Personalized Medicine · doi:10.2217/pme.09.32 · Cited by 2
The Affective Disorder Test: a new test to assess depression and anxiety-like behaviour in rats
Blackburne, K. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16840765.v1 · Cited by 2
Glavač, T., Barbo, M., Ravnik-Glavač, M., Zupančič, M., & Dolžan, V. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675538 · Cited by 1
Chapter 4.7 The pharmacology of anxiolysis
Holmes, A. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00016-1 · Cited by 1
Pharmacogenetics of Major Depressive Disorder
Lohoff, F. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080601-05 · Cited by 4
Psychopharmacogenomics in Pediatric Psychiatry with a Focus on Cytochrome P450 Testing
Malik, S., & Azeem, M. W. (2016) · Psychiatric Annals · doi:10.3928/00485713-20151130-01 · Cited by 1
Cp, T., Ac, L., Mohamed, Z., & Nz, Z. (2013) · The Malaysian journal of psychiatry · Cited by 1
Pharmacogenetics in Psychiatry
Tsapakis, E. M., Curran, S. R., Ohlsen, R. I., Vyas, N. S., Aitchison, K. J., & Daly, A. K. (2012) · Wiley eBooks · doi:10.1002/9781118116494.ch7 · Cited by 1
Hernán Silva, I., Iturra, P., Solari, A., Juana Villarroel, G., Sonia Jerez, C., Roa, N., & María Leonor Bustamante, C. (2010) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272010000200004 · Cited by 1
Pharmacogenomics in Psychiatric Disorders
Lam, Y. W. F., Fukui, N., Sugai, T., Watanabe, J., Watanabe, Y., Suzuki, Y., & Someya, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00006-8 · Cited by 2
The Pharmacist’s Perspective on Pharmacogenetics Implementation
Weitendorf, F., & Reynolds, K. K. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.05.009 · Cited by 1
Lapid, M. I., Kung, S., Frye, M. A., Biernacka, J. M., Geske, J. R., Drake, M. T., Jankowski, M. D., & Clarke, B. L. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.184 · Cited by 4
Genetic and clinical predictors of treatment efficacy in depressive disorders
Ivanets, N. N., Kinkulkina, M. A., Tikhonova, Y. G., Izyumina, T. A., Avdeeva, T. I., & Morozov, D. I. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201711710155-64 · Cited by 1
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Asadi, S., Rashidi, F. S., Shams, J., & Ahmadiani, A. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.25.4.3 · Cited by 1
“Many studies investigated the association of SLC6A4 variations with response to SSRIs in patients with depressive disorders (Kato and Serretti, 2010; Lesch and Gutknecht, 2005; Porcelli et al., 2012; Serretti et al., 2007).”
BackgroundMethodCzarnecki, D., Ziółkowski, M., Chodkiewicz, J., Gorzkiewicz, M., Waszkiewicz, N., Długosz, A., Budzyński, J., Junkiert-Czarnecka, A., & Kułak-Bejda, A. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s384935 · Cited by 1
“To date, a positive association of the 5-HTTLPR gene polymorphism of the short (S) or short/short (S/S) allele (short allele) with alcohol dependence, the greater emotional arousal, lowered mood and, in the case of the long (L) allele, a positive association with response to drug treatment in alcohol-dependent individ…”
BackgroundRole of Membrane Transporters in Pharmacogenomics
Bach‐Rojecky, L., Primorac, D., Topić, E., Štefanović, M., & Höppner, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-45903-0_4 · Cited by 1
Intervention options: depression and cardiovascular disease during COVID-19
Flouda, E., Stefanatou, A., & Apergi, T. (2023) · Global Cardiology · doi:10.4081/globalcard.2023.5 · Cited by 2
Integrated study on the mRNA expression of the human serotonin transporter
Vijayendran, M. (2012) · doi:10.17077/etd.z7s3cof7 · Cited by 1
Maier, W., Zobel, A. W., & Schwab, S. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-33129-2_4 · Cited by 4
Depression in Clinical Practice
Rabbani, M. (1970) · Bangladesh Medical Journal · doi:10.3329/bmj.v40i1.9954 · Cited by 1
Pae, C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.001 · Cited by 1
Dynamic and Systems-Based Models for Evaluating Hypotheses Related to Predicting Treatment Response
Stoltenberg, S. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_64 · Cited by 1
The promise of biomarkers and response prediction
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.028
Pharmacogenetics and mood disorders
Laje, G., & McMahon, F. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.029
Pharmacogenetics of Drug Targets
Daly, A. K., & Arranz, M. J. (2012) · Wiley eBooks · doi:10.1002/9781118116494.ch5 · Cited by 1
TREATMENT OF DEPRESSION IN ELDERLY PATIENTS WITH CARDIOVASCULAR DISEASE
Sumardika, I. W., & Diniari, N. K. S. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Hougardy, D. M. C., Egberts, T. C. G., van der Graaf, F., Brenninkmeijer, V. J., & Derijks, L. J. J. (2007) · Pharmaceutisch Weekblad
Genetics of mood disorders : from pharmacogenetics to disease genetics
Serretti, A. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20081126as
Self-citationCOCAINE DEPENDENCE: THE ROLE OF SEROTONIN GENES IN
Maili, L. (2011) · Digital Commons-TMC (Texas Medical Center)
Neuropharmacogenetics of Major Depression: Has the Time Come to Take both Sexes into Account?
Pothitos, M., Sanoudou, D., Dalla, C., & Papadopoulou‐Daifoti, Z. (2012) · InTech eBooks · doi:10.5772/26634
“This notion has been attributed to a generalized responsiveness of the serotonergic system owing to the enhanced expression/activity of 5-HTT (Serretti et al. , 2007).”
Villafuerte, S. M., Rubenfire, M., & Kronfol, Z. (2011) · Wiley eBooks · doi:10.1002/9780470975138.ch14
Alcune considerazioni sulla farmacogenetica della risposta agli antidepressivi
Veglia, T. A., Messina, E., Nosari, G., & Politi, P. (2013) · Università degli Studi di Pavia · doi:10.6092/2039-1404.126.1569
“Alcuni studi [9-10] hanno dimostrato che le ca use di questa povera risposta agli antidepressivi è da ricercarsi nell’eterogeneità clinica, nell’incer tezza diagnostica, nella comorbidità, nei fattori a mbientali, sociali e genetici.”
BackgroundResearch Highlights: Continuous Un-Sert-Ainty of 5-HTTLPR
Shinozaki, G. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.80
Gressier, F., Verstuyft, C., Bouaziz-Amar, É., Hardy, P., Becquemont, L., & Corruble, E. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70251-7
Pharmacogenetics—A Useful Tool in Antidepressant Pharmacotherapy?
Domschke, K. (2008) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2008.13.4.1
Lack of Association Between COMT Gene Polymorphism and Treatment Outcome in Major Depression
Selek, S., Kaya, M., Erdal, M. E., Bulut, M., Özen, M. E., Yumru, M., Barlas, O., Kalenderoğlu, A., & Herken, H. (2011) · DergiPark (Istanbul University)
Natarajan, D. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Lonsdorf, T. B. (2010) · Figshare
Phillips, J. L. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-2800
“and more delayed response to SSRIs among MDD patients homozygous for the 5HTTLPR S allele (Smits et al., 2004; Serretti et al., 2007), and better response and remission rates in association with the L allele (Porcelli et al.”
BackgroundInfluentialMuhonen, L. H. (2008) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 1
Estudio farmacogenómico en Trastorno Límite de Personalidad.
Hernán Silva, I., Iturra, P., Solari, A., Juana Villarroel, G., Sonia Jerez, C., Roa, N., & Bustamante, M. L. (2013) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v71i1-4.1631
INSTITUTO DE NEUROCIENCIAS "FEDERICO OLÓRIZ"
Medicina, F. D. (2008)
ANTIDEPRESSANTS AND PANIC DISORDER
Neuropsychiatry, C., Andrisano, C., Balzarro, B., Fabbri, C., Chiesa, A., & Serretti, A. (2012) · Cited by 2
Self-citationDouleur chronique : rôle de la pharmacogénétique dans la résistance aux antidépresseurs
Rodieux, F., Berney, P., Desmeules, J. A., & Besson, M. J. (2013) · Douleur et Analgésie · doi:10.1007/s11724-013-0355-7
“et escitalopram [2,40,52]”
AL-Eitan, L. N. (2012) · UWA Profiles and Research Repository (University of Western Australia)
Genetic variation and attentional and memory biases for emotional information
Naudts, K. H. (2012) · Ghent University Academic Bibliography (Ghent University)
SÖÖMISHÄIRETE DIMENSIONAALNE LIIGITAMINE: LATENTSETE PROFIILIDE ANALÜÜS
Kivimäe, M. (2015) · DSpace repository (University of Tartu)
Prediction of Treatment Response in Depression Based on Genetic Factors from the Practical Viewpoint
Kato, M. (2013) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.44.117
Self-citationDoes 5HTTLPR long allele prevent hospitalization? Test of Hardy–Weinberg equilibrium
Shinozaki, G., Kung, S., & Mrazek, D. A. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000024
“Introduction The serotonin transporter gene promoter-linked polymorphic region (5HTTLPR) has been studied extensively in psychiatric genetics research over recent decades, and many studies suggest an association of the serotonin transporter gene promoter polymorphism (5HTTLPR) long (l) allele with better antidepressan…”
BackgroundResultInfluentialEitan, R., Landshut, G., & Lerer, B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576393.004 · Cited by 1
Rudberg, I. (2010) · NORA - Norwegian Open Research Archives · Cited by 1
Pharmacogenomic Variability Associated with Psychotropic Medication Response
Mrazek, D. A., & Kolla, B. P. (2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814405614_0029
López, A. C. (2016) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
Hvis du skal gjøre det, gjør det riktig!
Solberg, D. K., Refsum, H., & Molden, E. (2017) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.0441
Won, E., Ham, B., & Kim, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-6580-4_2
Ferreira, M. M. F. S. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/0jma-9k59
Pharmacogenetics of Major Depressive Disorder (MDD): Progress in Two Serotonergic Targets
Iro, C. M., & Hamati, R. (2018) · University of Ottawa Journal of Medicine · doi:10.18192/uojm.v8i2.3858
The role of pharmacogenetics in the treatment of depression
Chan, A. R., Gorbovskaya, I., & Müller, D. J. (2019) · Oxford University Press eBooks · doi:10.1093/oso/9780198793014.003.0027
Pharmacogenomics of treatment response in major depressive disorder
Biernacka, J. M., Ahmed, A. T., Singh, B., & Frye, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00033-x
Imaging Genetic and Epigenetic Markers in Mood Disorders
Poletti, S., Mazza, E. A., Vai, B., & Benedetti, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.012
Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders
Kumar, P., Jiang, Y., & Whitton, A. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.006
Resting-State Functional Connectivity in Unipolar Depression
Chen, Z., & Gong, Q. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.007
Brain Imaging Methods in Mood Disorders
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.002
Kious, B. M., & Renshaw, P. F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.009
Neuroimaging Brain Inflammation in Mood Disorders
Meyer, J. H. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.011
Functional Near-Infrared Spectroscopy Studies in Mood Disorders
Matsuo, K., & Matsubara, T. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.014
Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus
Arnone, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.003
Neuroimaging Biomarkers in Pediatric Mood Disorders
West, M. P., Tang, W. J., & Singh, M. K. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.005
fMRI Neurofeedback as Treatment for Depression
Skottnik, L., & Linden, D. E. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.013
Neuroanatomical Findings in Bipolar Disorder
Tronchin, G., & McDonald, C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.004
Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders
Scotti-Muzzi, E., Otaduy, M. C. G., Soeiro‐de‐Souza, M. G., & Machado‐Vieira, R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.010
Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder
Jauhar, S. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.019
Magnetoencephalography Studies in Mood Disorders
Nugent, A. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.016
Was erklärbar ist: Ätiologie und Entwicklungspsychopathologie
Remschmidt, H., & Theisen, F. (2011) · Springer eBooks · doi:10.1007/978-3-540-36273-9_3
The mechanisms of serotonergic signaling in Drosophila
Borue, X. (2009) · doi:10.18130/v3nc4h
Sexual dysfunction in patients with MDD treated with SSRIs - causes, measurement and prevention
Giermasiński, A., Próchnicka, M., Nowak, D., Oszczędłowski, P., & Nowaczek, J. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.09.046 · Cited by 1
Pharmacogenomics of Psychiatric Drugs
Mrazek, D. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139051194.022
Tapnikar, S. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16910950 · Cited by 1
Clauss, N. J., & Daws, L. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00172-9
Personalized Pharmacotherapy: A Historical Perspective on the Pharmacogenomics of Depression
Perry, S. W., Licinio, J., & Wong, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00204-8
Pérez, P., & Arenaza, J. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-05870-2_23 · Cited by 2
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.022
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.796
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1 · Cited by 1
Holsboer‐Trachsler, E., & Holsboer, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_28 · Cited by 1
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.001
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
GELLER, D. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733025880.793554657
Pharmacogenetics in Psychotropic Drugs
Lee, J. A., & Lee, J. G. (2022) · Mood and Emotion · doi:10.35986/me.2022.20.1.1
Metadata
- Authors
- Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T.
- Affiliations
- University of Bologna (IT)
- Kansai Medical University (JP)
- Corresponding author
- Serretti, A
- Venue
- Molecular Psychiatry
- Published
- 2006-12-05
- Volume
- 12
- Issue
- 3
- Pages
- 247-257
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1982886582
- Cited by
- 529
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 44 · 2020: 10 · 2019: 18 · 2018: 22 · 2017: 23 · 2016: 28 · 2015: 29 · 2014: 23 · 2013: 38 · 2012: 39
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- 5-HTTLPR, serotonin transporter gene, promoter polymorphism, selective serotonin reuptake inhibitors, antidepressant response, depression, remission rate, genetic association, ethnic differences, Asian populations
- MeSH terms
- Adult, Aged, Depressive Disorder, Female, Humans, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, MEDLINE, Selective Serotonin Reuptake Inhibitors, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.